Mateusz Kaczmarek, Author at TechStock²

Marsh CEO Slams Rivals’ “Unlawful” Hiring Blitz as Shares Slide

Marsh & McLennan CEO John Doyle publicly accused rival brokers of “unlawful and unethical” talent raids during Marsh’s Oct. 16 earnings call Insuranceinsider Theinsurer. Doyle said competitors’ tactics were a “deliberate strategy” to flout non-compete covenants Insuranceinsider. The comments came amid a surge of legal battles – Marsh has sued peers like Alliant and Howden for allegedly poaching its teams and clients Insurancejournal Insurancebusinessmag. In Q3, Marsh reported $6.4 billion revenue (up 11% YoY) and $911 million adjusted profit Reuters, but its stock still plunged ~8% on the day Reuters, trading around $190 (mid-Oct. 2025) Stockanalysis. Analysts remain cautiously bullish: the consensus

19 October 2025

Business News·NYSE:MMC·Stock Market

Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Stock Price & Recent Performance Before the late-September rally, Pfizer’s stock had been trading lethargically. As one analysis notes, PFE closed around $23.60 on Sept. 26, roughly flat for the year and down ~9% since January ts2.tech. Over the prior 12 months it had fallen about 18%, weighed down by fading COVID sales and patent losses ts2.tech. Its 52-week range was about $20.9–$30.4 ts2.tech, so the recent surge took it to the upper end of that range. The catalyst was clear: on Sept. 30 Trump’s administration announced the Pfizer pricing deal, and PFE instantly rallied. Shares jumped about 6–7% on

19 October 2025

Business News·Investment·Market Analysis·Pharmaceuticals·Stocks

Adobe Stock Tanks Near 52-Week Low – Is AI to Blame?

Stock Performance As of mid-October 2025, ADBE is trading around $330 marketbeat.com. This level is near its 52-week lows (about $329) and far below 2024’s peak (~$555) ts2.tech. Over the past month the stock has fallen roughly 10–15%, and it is down about 20–25% YTD. Last week saw a small bounce (the stock was up ~1% on Oct 17) marketbeat.com, but the trend remains down. In technical terms, ADBE sits below both its 50-day and 200-day moving averages (recently ~$351 and ~$369, respectively marketbeat.com), reflecting its slide. The current valuation is relatively low: trailing P/E around 21x and forward P/E

19 October 2025

Artificial Intelligence·Investment Analysis·Stock Market·Technology News

Navitas (NVTS) Stock Skyrockets on NVIDIA AI Chip News — Record Rally Sparks Bull-Bear Debate

NVTS Stock Rally and Recent Performance Navitas’s stock has exploded higher in mid-October. On Oct. 13 (Monday), NVTS jumped ~17–21% intraday after markets when the company announced new GaN/SiC power devices for NVIDIA’s next-gen data centers ts2.tech finviz.com. The rally accelerated each day: by Oct. 16 NVTS closed at $15.63, its highest ever, following five straight gains ts2.tech ts2.tech. Overall, Navitas shares nearly doubled in one week, climbing from roughly $8 to $15+ ts2.tech. Even on Oct. 17 the stock remained elevated (closing $14.66, down 6.2% for the day) stockanalysis.com. Daily/weekly trend: This October run is far above the stock’s

19 October 2025

AI Technology·Financial News·Investment Analysis·Semiconductor Industry·Stock Market

IBM Stock Soars 28%: AI & Cloud Breakthroughs Fuel Historic Rally

Stock Performance & Recent Moves IBM’s stock has been on a tear in fall 2025. After bottoming near $210 last August, it has rallied into the high $270s–$280s. For example, it closed around $279 on Oct. 13, just shy of its late-September peak (~$296) ts2.tech. This roughly 28% YTD gain greatly outstrips the S&P 500’s YTD rise ts2.tech. In mid-October the stock pushed higher on news flow: after closing around $276 on Oct. 13, it closed $281.28 (+1.9%) on Oct. 17 stockanalysis.com. Trading volume has ticked up with the rally, as investors cheer IBM’s tech pivot. Investors credit IBM’s recent

19 October 2025

Artificial Intelligence·Cloud Computing·Investing·Stock Market·Technology News

ASML Stock Skyrockets on AI Boom – Analysts Warn China Slump Looms

Stock Performance & Market Rally ASML’s stock has been on a tear in October 2025. After a late summer rally, shares continued climbing following the Q3 report. For example, on Oct. 15 the NASDAQ-listed ASML ADS closed at $1,009.81 – a 2.7% gain on the day marketbeat.com – and hit intraday highs above $1,030. By the Oct. 17 close the ADS price was roughly $1,029 (≈€880), just shy of the record $1,059 set earlier in the year ts2.tech. This rally has far outpaced the broader semiconductor index: since early September ASML is up ~+32% ts2.tech. The surge reflects robust demand

19 October 2025

AI Technology·Global Economy·Investment·Semiconductor Industry·Stock Market

Chevron (CVX) Stock Rallies on $2B Pipeline Deal – Could $200 Be Next?

CVX Stock Price & Recent Performance Chevron (NYSE: CVX) has traded mostly sideways in October 2025. After closing ~$151.71 on Oct. 16, 2025, the stock rose ~0.9% to $153.08 on Oct. 17 reuters.com. The share price has lingered in a narrow $150–154 range this week ts2.tech, roughly flat over 5 days. Year-to-date CVX lags the broad market, reflecting weaker oil and the drag from the Hess merger ts2.tech. Still, technical indicators show the stock holding key support in the mid-$140s ts2.tech. Trading volume is moderate (about 7–8M shares daily) and volatility is low, mirroring the calm in global energy markets.

19 October 2025

Energy Sector·Financial News·Investing·Oil & Gas·Stock Market

AI Boom’s Hidden Gem: Credo (CRDO) Stock Soars on $500 “Purple” Cables and Big Partnerships

CRDO’s Wild Ride on AI Hype Credo (NASDAQ: CRDO) has become one of 2025’s hottest AI infrastructure stocks. The company makes advanced cables and chips that connect GPUs inside AI supercomputers. In late September, Elon Musk’s xAI even showcased “thousands” of Credo’s bright purple cables in its new Colossus 2 data center rufinfeed.ru, underscoring the mystique around the firm’s products. Credo’s shares have soared over 1,300% since its 2022 IPO ts2.tech as the AI boom has made its AEC (active electrical cable) technology nearly indispensable: today Credo commands an ~88% share of the emerging multi-billion dollar AEC market rufinfeed.ru. This

19 October 2025

Artificial Intelligence·Investment Opportunities·NASDAQ:CRDO·Stock Market

Shocking U-Turn: Social Security Paper Checks Saved – Trump’s Stimulus Check Hype Debunked, Stocks Soar

What’s Behind the Paper-Check Change? In March 2025 President Trump signed an executive order (EO 14247) directing agencies to “eliminate physical payments…to the extent permitted by law” kiplinger.com. By late summer, Treasury and SSA announced a Sept. 30 deadline to switch benefit checks to direct deposit or Treasury’s prepaid Direct Express card ssa.gov home.treasury.gov. The goal: save taxpayer money and speed payments. As Treasury put it, digital transfers “are safer, faster, and far more efficient” home.treasury.gov. (In fact, each mailed check costs about 50¢ to produce vs 15¢ electronically hindustantimes.com.) SSA encouraged beneficiaries to enroll in direct deposit via their “my Social

19 October 2025

Financial News·Social Security·Stock Market

Rigetti (RGTI) Stock Rockets 5,000% on Big Quantum Deals — Bubble Warning Looms

Record Run and Sharp Reversal In 2025 Rigetti’s stock became one of the year’s wildest stories. As of Oct. 19, RGTI trades in the mid-$40s, having earlier hit an all-time high ~$56.34 on Oct. 15 ts2.tech. That marked roughly a 50‑fold gain over its price a year earlier – a staggering climb fueled by “quantum computing fever,” as TechStock² (TS2) reports ts2.tech. In one week RGTI rocketed from the mid-$40s to the mid-$50s, including a single-day surge of ~25% on Oct. 13 ts2.tech. This frenzy put Rigetti’s market cap at roughly $17B (again, on single-digit millions in revenue) ts2.tech. Investors piled in on

19 October 2025

Financial Analysis·Investing·Quantum Computing·Stock Market·Tech News

Intel Stock Explodes: 10% U.S. Stake, Nvidia Deal & AI Hype Fuel Surge

Intel’s stock market roller-coaster has become one of 2025’s top stories. After languishing in the teens and low-$20s in early 2025, INTC shares have roared higher in recent months. By Oct. 17 the stock closed around $37, its highest since 2023 ts2.tech. As TS2.tech notes, the shares have “nearly doubled from its lows in January” on hopes of a turnaround ts2.tech. Much of the surge is tied to investor excitement over Intel’s role in the AI chip revolution and a flurry of unexpected big-money deals. One key catalyst was Washington’s intervention. In late August the Trump administration announced it would

19 October 2025

Artificial Intelligence·Investment Insights·Semiconductor Industry·Stock Market·Technology News

BigBear.ai (BBAI) Stock Skyrockets on New Defense AI Deals – Is It the Next Palantir?

Bottom Line: BigBear.ai has captured imaginations as a small-cap AI company riding the defense boom. Its recent multi-million-dollar U.S. government partnerships have triggered large price moves – but also come with big caveats. As one market note put it, BigBear.ai’s story is “highly volatile” ts2.tech. For now, BBAI’s share price reflects both the promise of its cutting-edge tech and the uncertainty of turning that promise into profit citybiz.co ts2.tech. Investors and analysts alike will be watching closely to see if the company can execute on its new edge-AI strategies and sustain growth, or if this surge was a short-lived (albeit

19 October 2025

Artificial Intelligence·Defense Industry·Market Trends·Stock Analysis·Technology

Previous 1 … 120 121 122 123 124 … 233 Next

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 07.02.2026

7 February 2026

LIVEMarkets rolling coverageStarted: February 7, 2026, 12:00 AM ESTUpdated: February 7, 2026, 12:49 AM EST CSL Faces Growth Uncertainty Amid Seqirus Spin-off Pause and Flu Vaccine Demand Drop February 7, 2026, 12:49 AM EST. CSL (ASX:CSL) confronts near-term challenges after delaying its Seqirus vaccine unit spin-off due to weaker U.S. flu vaccination uptake, impacting its fiscal 2026 growth outlook. Regulatory scrutiny in Europe over its Tavneos kidney therapy data, plus intensifying U.S. competition for its Vifor iron products, heighten concerns over product credibility and pricing pressure. Despite these headwinds, CSL's diversified portfolio in plasma, vaccines, and kidney therapies underpins its

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026

Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026

Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026

Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.